Literature DB >> 15182936

Oxygen binding and oxidation reactions of human hemoglobin conjugated to carboxylate dextran.

Yiping Jia1, Francine Wood, Patrick Menu, Béatrice Faivre, Alexis Caron, Abdu I Alayash.   

Abstract

Human hemoglobin (Hb) conjugated to benzene tetracarboxylate substituted dextran produces a polymeric Hb (Dex-BTC-Hb) with similar oxygen affinity to that of red blood cells (P(50)=28-29 mm Hg). Under physiological conditions, the oxygen affinity (P(50)) of Dex-BTC-Hb is 26 mm Hg, while that of native purified human HbA(0) is 14 mm Hg, but it exhibits a slight reduction in cooperativity (n(50)), Bohr effect, and lacks sensitivity to inositol hexaphosphate (IHP), when compared to HbA(0). Oxygen-binding kinetics, measured by rapid mixing stopped-flow method showed comparable oxygen dissociation and association rates for both HbA(0) and Dex-BTC-Hb. The rate constant for NO-mediated oxidation of the oxy form of Dex-BTC-Hb, which is governed by NO entry to the heme pocket, was reduced to half of the value obtained for HbA(0). Moreover, Dex-BTC-Hb is only slightly more sensitive to oxidative reactions than HbA(0), as shown by about 2-fold increase in autoxidation, and slightly higher H(2)O(2) reaction and heme degradation rates. Dextran-BTC-based modification of Hb produced an oxygen-carrying compound with increased oxygen release rates, decreased oxygen affinity and reduced nitric oxide scavenging, desirable properties for a viable blood substitute. However, the reduction in the allosteric function of this protein and the lack of apparent quaternary T-->R transition may hinder its physiological role as an oxygen transporter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182936     DOI: 10.1016/j.bbagen.2004.03.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Oxygen delivery using engineered microparticles.

Authors:  Raymond P Seekell; Andrew T Lock; Yifeng Peng; Alexis R Cole; Dorothy A Perry; John N Kheir; Brian D Polizzotti
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

2.  Enhanced nitrite reductase activity associated with the haptoglobin complexed hemoglobin dimer: functional and antioxidative implications.

Authors:  Camille J Roche; David Dantsker; Abdu I Alayash; Joel M Friedman
Journal:  Nitric Oxide       Date:  2012-04-18       Impact factor: 4.427

3.  Post-translational transformation of methionine to aspartate is catalyzed by heme iron and driven by peroxide: a novel subunit-specific mechanism in hemoglobin.

Authors:  Michael Brad Strader; Wayne A Hicks; Tigist Kassa; Eileen Singleton; Jayashree Soman; John S Olson; Mitchell J Weiss; Todd L Mollan; Michael T Wilson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

4.  Hydrogen-bonding conformations of tyrosine B10 tailor the hemeprotein reactivity of ferryl species.

Authors:  Walleska De Jesús-Bonilla; Anthony Cruz; Ariel Lewis; José Cerda; Daniel E Bacelo; Carmen L Cadilla; Juan López-Garriga
Journal:  J Biol Inorg Chem       Date:  2006-02-09       Impact factor: 3.358

5.  Next-generation polymerized human hemoglobins in hepatic bioreactor simulations.

Authors:  Clayton Cuddington; Savannah Moses; Donald Belcher; Niral Ramesh; Andre Palmer
Journal:  Biotechnol Prog       Date:  2020-01-21

Review 6.  Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility.

Authors:  Samira Moradi; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Clin Med Insights Blood Disord       Date:  2016-10-27

7.  Site-directed mutagenesis of cysteine residues alters oxidative stability of fetal hemoglobin.

Authors:  Karin Kettisen; Michael Brad Strader; Francine Wood; Abdu I Alayash; Leif Bülow
Journal:  Redox Biol       Date:  2018-08-22       Impact factor: 11.799

8.  Haptoglobin preferentially binds β but not α subunits cross-linked hemoglobin tetramers with minimal effects on ligand and redox reactions.

Authors:  Yiping Jia; Francine Wood; Paul W Buehler; Abdu I Alayash
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.